Selin Kurnaz's guest appearances

Selin Kurnaz

Precision Medicine Podcast

The Research Evangelist

Christian Rolfo

Sarah Cannon

Sarah Goldberg

Anthony Greco

Leora Horn

Jun Zhang

Lori Hall

Charu Aggarwal

Jack West

Nathan Pennell

Christopher Boone

Robin Toft

Lecia Sequist

David Spigel

Eric Grogan

OwlTail

On today's episode, meet Dr. Selin Kurnaz, Co-founder and CEO of Massive Bio. She is a hard-core engineer who started Massive Bio after a family situation in cancer because she is obsessed with enabling access to clinical trials to cancer patients around the globe. She believes all people should have equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay. Massive Bio is on a mission to build and lead the Amazonization of the patient enrollment value chain in oncology.

On today's episode, meet <a href="https://www.linkedin.com/in/selinkurnaz" rel="nofollow" target="_blank">Dr. Selin Kurnaz, Co-founder and CEO of Massive Bio</a>. She is a hard-core engineer who started <a href="https://massivebio.com/selin-kurnaz-shares-upbringing-and-startup-success/" rel="nofollow" target="_blank">Massive Bio</a> after a family situation in cancer because she is obsessed with enabling access to clinical trials to cancer patients around the globe. She believes all people should have equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay. Massive Bio is on a mission to build and lead the Amazonization of the patient enrollment value chain in oncology.

Meet Selin Kurnaz, PhD, co-founder/CEO of Massive Bio. She is on a mission to make sure that every cancer patient gets access to clinical trials.

In this episode, we speak with Dr. Selin Kurnaz, CEO and cofounder of Massive Bio, who led a panel at the Precision Medicine Leadership Summit in Philadelphia. The panel discussion, Precision Medicine Clinical Trials and Novel Designs: Levering Data, ‘Omics’, AI and Policy focused on the importance of increasing patient accessibility to clinical trials, an issue that drove Dr. Kurnaz to cofound her company. Read more in our full summary and tune in to the episode here.

In this episode, we speak with Dr. Selin Kurnaz, CEO and cofounder of Massive Bio, who led a panel at the <a>Precision Medicine Leadership Summit</a> in Philadelphia. The panel discussion, Precision Medicine Clinical Trials and Novel Designs: Levering Data, ‘Omics’, AI and Policy focused on the importance of increasing patient accessibility to clinical trials, an issue that drove Dr. Kurnaz to cofound her company. <a href="https://www.interventioninsights.com/kurnaz-clinical-trial-access" rel="nofollow" target="_blank">Read more in our full summary and tune in to the episode here.</a>

Dr. Selin Kurnaz of Massive Bio Explains the Need to Operationalize Patient Support in Precision Cancer Care